Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. Fully revised and updated, the report provides details of option and evaluation deals from 2019 to 2025.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of option and evaluation deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in option and evaluation as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of option and evaluation deals.
Chapter 4 provides a review of the leading option and evaluation deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active option and evaluation dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of option and evaluation deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the option and evaluation deal.
The deal directory includes a comprehensive listing of all option and evaluation deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in option and evaluation dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about option and evaluation alliances.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for option and evaluation deals, including contract documents where available.
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2019
- Browse option and evaluation deals
- Benchmark analysis - identify market value of transactions
- Financials terms
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of option and evaluation deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual option and evaluation contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of option and evaluation dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in option and evaluation as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of option and evaluation deals.
Chapter 4 provides a review of the leading option and evaluation deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active option and evaluation dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of option and evaluation deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the option and evaluation deal.
The deal directory includes a comprehensive listing of all option and evaluation deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in option and evaluation dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about option and evaluation alliances.
Report Scope
Option and Evaluation Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the option and evaluation trends and structure of deals entered into by leading biopharma companies worldwide.Option and Evaluation Deals in Pharmaceuticals and Biotechnology includes:
- Trends in option and evaluation dealmaking in the biopharma industry
- Overview of option and evaluation deal structure
- Directory of option and evaluation deal records covering pharmaceutical and biotechnology
- The leading option and evaluation deals by value
- Most active option and evaluation dealmakers
- The leading option and evaluation partnering resources
In Option and Evaluation Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for option and evaluation deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Chapter 1 - Introduction
Chapter 2 - Trends in option and evaluation dealmaking
Chapter 3 - Overview of option and evaluation deal structure
Chapter 4 - Leading option and evaluation deals
Chapter 5 - Top 25 most active option and evaluation dealmakers
Chapter 6 - option and evaluation deals including contracts directory
Deal directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2cureX
- 2seventy bio
- 3B Pharmaceuticals
- 3D Medicines
- 3SBio
- 3T Biosciences
- 4D Molecular Therapeutics
- 4D Pharma
- 9 Meters Biopharma
- 23andMe
- 48Hour Discovery
- A2 Biotherapeutics
- A2A Pharmaceuticals
- Aarvik Therapeutics
- AB2 Bio
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- Abeona Therapeutics
- Abera Bioscience
- Abilita Therapeutics
- AbSci
- Accent Therapeutics
- Acelyrin
- Acepodia
- Acer Therapeutics
- Ache
- Achilles Therapeutics
- AC Immune
- Acuitas Therapeutics
- Adagene
- Adaptimmune
- Adaptive Phage Therapeutics
- AdaptVac
- Adcendo
- ADC Therapeutics
- Addario Lung Cancer Medical Institute
- Adhera Therapeutics
- Adimab
- Aditum Bio
- AdoRx Therapeutics
- ADT Pharmaceuticals
- Advaite
- Advancium Health Network
- Aegea Biotechnologies
- Aelis Pharma
- Aequus Pharmaceuticals
- Aerpio Pharmaceuticals
- Aethon Therapeutics
- Aevi Genomic Medicine
- Aexon Labs
- Affibody
- Affini-T Therapeutics
- Affinia Therapeutics
- Agenus Bio
- AgeX Therapeutics
- AgNovos Healthcare
- AIkido Pharma
- Aileron Therapeutics
- Ainos
- AI Proteins
- Aitia
- Ajinomoto
- AJU Pharma
- Akcea Therapeutics
- Akebia Therapeutics
- Akero Therapeutics
- Akston Biosciences
- Aldeyra Therapeutics
- Alector
- Alexion Pharmaceuticals
- Alfasigma
- Aligos Therapeutics
- AlivaMab Discovery Services
- Alivio Therapeutics
- Allarity Therapeutics
- Allegro Ophthalmics
- Allergan
- Allergan Aesthetics
- Alligator Bioscience
- Allist Pharma
- Allogene Therapeutics
- Allorion Therapeutics
- Almirall
- Alnylam Pharmaceuticals
- Alphageneron Pharmaceuticals
- Alpine Immune Sciences
- Altamira Therapeutics
- Altavant Sciences
- Alternavida
- Amagma Therapeutics
- Amasa Therapeutics
- Amathus Therapeutics
- Amerimmune
- Amgen
- AmMax Bio
- Amolyt Pharma
- ANANDA Scientific
- Anchiano Therapeutics
- Anergis
- Angelini Pharma
- Anima Biotech
- Antares Pharma
- Antengene
- Apellis Pharmaceuticals
- Applied DNA Sciences
- Apricity Health
- Aptorum Group
- Aqemia
- Aqilion
- Araris Biotech
- Arbutus
- ARCA Biopharma
- Arcellx
- Arcturus Therapeutics
- Arcus Biosciences
- Ardelyx
- Arecor
- Arena Pharmaceuticals
- Ares Genetics
- Ariceum Therapeutics
- Aridis Pharmaceuticals
- Aristea Therapeutics
- Arkuda Therapeutics
- Arovella Therapeutics
- Arrakis Therapeutics
- ArriVent Biopharma
- Arrowhead Pharmaceuticals
- Arsenal Biosciences
- Artios Pharma
- Artisan Bio
- Artiva Biotherapeutics
- Artizan Biosciences
- Aruvant Sciences
- Asahi Kasei
- Ascentage Pharma
- ASC Therapeutics
- Asep Medical
- Asher Bio
- Asieris Pharmaceuticals
- ASKA Pharmaceuticals
- Asklepios Biopharmaceutical
- Aslan Pharma
- Assembly Biosciences
- Astellas Institute for Regenerative Medicine
- Astellas Pharma
- Astellas Pharma US
- Astex Pharmaceuticals
- AstraZeneca
- ATAI Life Sciences
- Atara Biotherapeutics
- Atavistik Bio
- Ateria Health
- Athebio
- Atossa Therapeutics
- Atreca
- Attralus
- AuraVax Therapeutics
- Aurigene Discovery Technologies
- Aurora Cannabis
- Autolus
- Avenzo Therapeutics
- AVEO Oncology
- AviadoBio
- Avicenna Biosciences
- Avita Therapeutics
- Avrobio
- Aytu BioPharma
- Aziyo Biologics
- Azura Ophthalmics
- BASE10 Genetics
- Basilea Pharmaceutica
- Battelle
- Bausch & Lomb
- Bausch Health Companies
- Baxalta
- Baxter International
- Bayer
- Bayer CropScience
- Baylor College of Medicine
- Baylor Scott and White Research Institute
- Beacon Therapeutics
- Beam Therapeutics
- BeiGene
- Belharra Therapeutics
- Bellicum Pharmaceuticals
- BGN Technologies
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Bintai Kinden
- Bio-Rad Laboratories
- Bio-Thera Solutions
- BioAge Labs
- BioArctic AB
- biOasis Technologies
- BioCardia
- Biocept
- Biocytogen
- Biodesix
- Biodextris
- Biogen
- Biohaven Pharmaceuticals
- BioInvent
- Biolojic Design
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BioMotiv
- Biomunex Pharmaceuticals
- BiomX
- Biond Biologics
- BiondVax
- Bioniz Therapeutics
- BioNova Pharmaceuticals
- BioNTech
- Biorchestra
- Biosplice
- Biotheus
- Bit Bio
- Bliss Biopharmaceutical
- Bloom Science
- Bluebird Bio
- Blueprint Medicines
- BlueRock Therapeutics
- Boehringer Ingelheim
- Bohai Biomedical
- Bold Therapeutics
- Bolt Biotherapeutics
- Boston Immune Technologies and Therapeutics
- Boston Pharmaceuticals
- Brammer Bio
- BriaCell Therapeutics
- BridgeBio Pharma
- BrightPath Biotherapeutics
- Bright Peak Therapeutics
- Bristol-Myers Squibb
- Bruno Farmaceutici
- Byondis
- C4 Therapeutics
- C4X Discovery
- Cabaletta Bio
- Caelum Biosciences
- Calder Biosciences
- Califia Pharma
- CanAm Bioresearch
- CANbridge Pharmaceuticals
- Cancer Genetics
- Cancer Research UK
- Cannabix Technologies
- Cannassure Therapeutics
- Capsida Biotherapeutics
- Captor Therapeutics
- Caraway Therapeutics
- Cardiff Oncology
- Cardiovascular Systems
- Caribou Biosciences
- Caris Life Sciences
- Carisma Therapeutics
- Carmine Therapeutics
- Carnegie Mellon University
- Cartography Biosciences
- Case Western Reserve University
- Catalent
- Catalyst Pharmaceuticals
- CBD Solutions
- Celcuity
- Celgene
- Cellares
- Cellectis
- Cellenkos
- Cellistic
- Celltrion
- Cellular Biomedicine
- Celmatix
- Celsius Therapeutics
- Century Therapeutics
- Cerveau Technologies
- Cevec Pharmaceuticals
- Champions Oncology
- Chansu Vascular Technologies
- Charles River Laboratories
- CHARM Therapeutics
- Checkmate Pharmaceuticals
- Checkpoint Therapeutics
- Chemify
- Chi-Med
- Chiesi Farmaceutici
- Children's Hospital Boston
- Children's Medical Research Institute
- Chimeric Therapeutics
- Chimeron Bio
- Cholesgen
- Chroma Medicine
- Chrysalis BioTherapeutics
- Chugai Pharmaceutical
- CiMaas
- Cimeio Therapeutics
- Citius Pharmaceuticals
- City of Hope
- Clavius Pharmaceuticals
- Clearmind Medicine
- Clearside Biomedical
- Cleveland Clinic
- Clover Biopharmaceuticals
- Coalition for Epidemic Preparedness Innovations
- Cocoon Biotech
- Code Biotherapeutics
- Codexis
- Codiak BioSciences
- Coeptis Pharmaceuticals
- Coeptis Therapeutics
- CohBar
- Coherus Biosciences
- CoImmune
- Collplant
- Columbia University
- Combotope Therapeutics
- Comera Life Sciences
- Conatus Pharmaceuticals
- Conduit Pharmaceuticals
- Confo Therapeutics
- Congruence Therapeutics
- Contera Pharma
- Context Therapeutics
- Contineum Therapeutics
- ContraFect
- Convelo Therapeutics
- COUR Pharmaceutical
- Coya Therapeutics
- Creatus Biosciences
- Crescendo Biologics
- CRISPR Therapeutics
- CSIRO
- CSL Behring
- CStone Pharmaceuticals
- Cue Biopharma
- Cugene
- Cullgen
- Cullinan Oncology
- Curasight
- CUREator
- CureVac
- Cureverse
- Curis
- Cyclica
- Cyclo Therapeutics
- Cynata Therapeutics
- Cyntar Ventures
- Cyrano Therapeutics
- Cystic Fibrosis Foundation
- Cytiva
- Cytocom
- CytomX Therapeutics
- CYTOVIA Therapeutics
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- Dartmouth College
- Debiopharm
- Decibel Therapeutics
- Deep Genomics
- Defence Research and Development Canada
- Defence Therapeutics
- Deinove
- Dementia Discovery Fund
- Denali Therapeutics
- Denovo Biopharma
- Department of Defense
- Dermata Therapeutics
- Dermelix Biotherapeutics
- Dermira
- Deverra Therapeutics
- Devyser Diagnostics
- Dewpoint Therapeutics
- Dicerna Pharmaceuticals
- DiNAQOR
- DNA Link
- Door Pharmaceuticals
- DotBio
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- DS Biopharma
- DSM
- DualityBio
- Duke University
- Dunad Therapeutics
- Durect
- Dyadic International
- Dynacure
- Dyno Therapeutics
- DynPort Vaccine Company
- Eagle Pharmaceuticals
- Eckert & Ziegler
- Edesa Biotech
- Editas Medicine
- eFFECTOR Therapeutics
- Eisai
- Elanco
- Elektrofi
- Element Biosciences
- Eligo Bioscience
- Eli Lilly
- Elpiscience
- Elsie Biotechnologies
- Emendo Biotherapeutics
- Emergence Therapeutics
- Emmaus Life Sciences
- Empirico
- Enalare Therapeutics
- Enara Bio
- Energesis Pharmaceuticals
- Enesi Pharma
- Enigma Biomedical
- Enveric Biosciences
- EnWave
- Enzychem Lifesciences
- Enzyvant Science
- EpicentRx
- eQcell
- EQRx
- Equillium
- ErVimmune
- ESSA Pharma
- Eterna Therapeutics
- Eurocine Vaccines
- European Biomedical Research Institute of Salerno
- Evaxion Biotech
- Everads Therapy
- Everest Medicines
- Evofem Biosciences
- EvolveImmune Therapeutics
- Evopoint Biosciences
- EVOQ Therapeutics
- Evotec
- Evox Therapeutics
- Evozyne
- EVQLV
- Exacis Biotherapeutics
- Exelixis
- Exeltis
- Exicure
- Exopharm
- ExpreS2ion Biotechnologies
- Exscientia
- Eyam Vaccines and Immunotherapeutics
- EyePoint Pharmaceuticals
- F-Star Therapeutics
- Fabric Genomics
- Facit
- FairJourney Biologics
- Fate Therapeutics
- Fauna Bio
- Felix Biotechnology
- Fibrogen
- FightMND
- FivepHusion
- Flagship Pioneering
- Flare Therapeutics
- Forge Therapeutics
- Fortis Therapeutics
- Fosun Pharmaceutical
- Fred Hutchinson Cancer Research Center
- Frontier Medicines
- FSD Pharma
- FUJIFILM Cellular Dynamics
- Fusion Pharmaceuticals
- Fuzionaire Radioisotope Technologies
- Gadeta
- Galapagos
- Galderma
- Gamida Cell
- GC Cell
- GC Pharma
- Gedeon Richter
- GEMMA Biotherapeutics
- GenEdit
- Genentech
- General Inception
- Generation Bio
- Generex Biotechnology
- Genesis Therapeutics
- GeneTx Biotherapeutics
- Genevant Sciences
- GenFleet Therapeutics
- Genmab
- Genocea Biosciences
- Genome and Company
- Genome Biologics
- Gensaic
- Genzyme
- George Washington University
- German Cancer Research Center
- Gicell
- Gilead Sciences
- Gilgamesh Pharmaceuticals
- Glaukos
- Global Blood Therapeutics
- Global Cancer Technology
- Global Coalition for Adaptive Research
- Glycotope Biotechnology
- Glytherix
- Goldfinch Bio
- Grail
- Graphite Bio
- Graviton Bioscience
- Greenwich LifeSciences
- Gritstone Bio
- GSK
- Gurnet Point Capital
- Gyroscope Therapeutics
- Hadassah Medical Center
- HanchorBio
- Hansa Biopharma
- Harbinger Health
- Harpoon Therapeutics
- Harvard Medical School
- HavaH Therapeutics
- Haystack Oncology
- HCW Biologics
- Healx
- Heartseed
- Hebrew University of Jerusalem
- Heidelberg Pharma
- Helmholtz Zentrum Munchen
- Helocyte
- Henlius Biotech
- Hepalys Pharma
- HepaTx
- Heqet Therapeutics
- Herantis
- HiFiBio
- Hikma Pharmaceuticals
- Hillstream BioPharma
- Histogen
- HitGen
- HMNC Brain Health
- Hoffmann La Roche
- Homology Medicines
- Hookipa Pharma
- Hopstem Biotechnology
- Horizon Therapeutics
- Hospital for Sick Children
- Hoth Therapeutics
- HotSpot Therapeutics
- Houston Methodist Research Institute
- Huadong Medicine
- Hubro Therapeutics
- Hummingbird Bioscience
- Hutchmed
- I-mab
- i2O Therapeutics
- IASO Biotherapeutics
- Icagen
- Icahn School of Medicine at Mount Sinai
- Iconic Therapeutics
- Iconovo
- IDEAYA Biosciences
- Idorsia
- IFM Therapeutics
- IGAN Biosciences
- Iksuda Therapeutics
- Iktos
- Illumina
- Imbrium Therapeutics
- Immatics Biotechnologies
- Immix Biopharma
- Immuneering
- Immune Regulation
- Immune System Regulation
- ImmuNext
- Immunicom
- ImmunityBio
- ImmunoBiochem
- Immunocore
- ImmunoGen
- Immunome
- Immunomic Therapeutics
- Immunovia
- Immunscape
- Immuron
- Immusoft
- Immutep
- Imperial College London
- Imugene
- Imunon
- IMV
- In4Derm
- Incyclix Bio
- Incyte
- Indapta Therapeutics
- Indivior
- Infinity Pharmaceuticals
- InflammX Therapeutics
- iNGENu
- Inhibrx
- Inmagene Biopharmaceuticals
- Innovation Pharmaceuticals
- Innovent Biologics
- Insilico Medicine
- Insitro
- InSphero
- Inspirna
- Institut Curie
- Institute for Research in Immunology and Cancer – Commercialization of Research
- Institute of Molecular and Clinical Ophthalmology Basel
- Institut Pasteur
- Intarcia Therapeutics
- Intas Pharmaceuticals
- IntelGenx
- Intellia Therapeutics
- Intellikine
- IntoCell
- Intract Pharma
- iNtRON Biotechnology
- Invenra
- Inventiva
- InxMed
- iOncologi
- iOnctura
- Ionis Pharmaceuticals
- IONTAS
- IOVaxis Therapeutics
- iProgen Biotech
- Ipsen
- Ironwood Pharmaceuticals
- Isoprene Pharmaceuticals
- iSTAR Medical
- Italfarmaco
- iTeos Therapeutics
- ITM Isotopen Technologien
- Iveric Bio
- Ivy Brain Tumor Center
- Jacobio Pharmaceuticals
- JanOne
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Jasper Therapeutics
- Jazz Pharmaceuticals
- JCR Pharmaceuticals
- Jiangsu Alphamab
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Innovation
- Jubilant Therapeutics
- Junshi Biosciences
- Jura Bio
- JW Therapeutics
- KAHR Medical
- Kainos Medicines
- Kaken Pharmaceutical
- Kalbe Genexine Biologics
- Kansas State University
- Karveer Meditech
- KDAc Therapeutics
- Kedalion Therapeutics
- Kedrion
- Kelonia Therapeutics
- Kelun-Biotech Biopharmaceutical
- KemPharm
- Kezar Life Sciences
- Kindeva Drug Delivery
- Kindred Bio
- Kineta
- Kiniksa Pharmaceuticals
- KinoPharma
- Kite Pharma
- Klaria
- KM Biologics
- Krankenhaus Nordwest
- KSQ Therapeutics
- Kubota Vision
- Kukbo
- Kura Oncology
- Kymera Therapeutics
- Kyn Therapeutics
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- Kyowa Hakko Kirin Pharmaceuticals
- Kyverna Therapeutics
- Laboratoires Thea
- Laboratorios Ordesa
- La Jolla Institute for Allergy & Immunology
- Lantern Pharma
- Lantheus Holding
- Leap Therapeutics
- LegoChem Biosciences
- LeMaitre Vascular
- LEO Pharma
- Les Laboratoires Servier
- Leveragen
- LG Life Sciences
- LianBio
- Ligand Pharmaceuticals
- Light Chain Bioscience
- Likarda
- Liminal BioSciences
- Lineage Cell Therapeutics
- Linnaeus Therapeutics
- Lipidor
- Lipocine
- Lisata Therapeutics
- Livzon Mabpharm
- LogicBio Therapeutics
- LSU Health Sciences Center
- LTS Lohmann Therapie-Systeme
- Lumen Biomedical
- Luminary Therapeutics
- Luminostics
- Lundbeck
- Lupagen
- Lupus Therapeutics
- Lysogene
- Mabylon
- Macomics
- Macrogenics
- Magenta Therapeutics
- MAIA Biotechnology
- Mainz University Medical Centre
- Mallinckrodt Pharmaceuticals
- Mammoth Biosciences
- Manhattan BioSolutions
- MannKind Biopharmaceuticals
- Marengo Therapeutics
- Maruho
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Matinas Biopharma
- MaveriX Oncology
- Max-Planck
- Mayo Clinic
- MC2 Therapeutics
- McQuade Center for Strategic Research and Development
- MD Anderson Cancer Center
- Medical Technology Enterprise Consortium
- Medical University South Carolina
- Medice Arzneimittel Pütter
- MEDiC Life Sciences
- Medicure
- Medidata Solutions
- MediGene
- MediLink Therapeutics
- MeiraGTx
- Melior Pharmaceuticals
- Memorial Sloan Kettering Cancer Center
- Menarini
- Merck and Co
- Merck KGaA
- Merck Sharpe & Dohme
- Merdury Biopharmaceutical
- Mersana Therapeutics
- Merus
- Merz
- Mesoblast
- Mestag Therapeutics
- Metagenomi
- MetVital
- MicroQuin
- Millennium
- MiMedx
- Mimetas
- MiNA Therapeutics
- MindBio Therapeutics
- MindPeak
- Mirati Therapeutics
- Mirimus
- Mirror Biologics
- Mirum Pharmaceuticals
- Mitokinin
- Mitsubishi Chemical
- Mitsubishi Tanabe Pharma
- MockV Solutions
- Moderna
- Modulus Discovery
- Molecular Partners
- Molecular Templates
- Moleculin Biotech
- Molecure
- MOMA Therapeutics
- Monte Rosa Therapeutics
- Morphic Therapeutic
- MorphoSys
- Mor Research Applications
- Mosaic ImmunoEngineering
- MSD
- Multimmune
- Multiply Labs
- Mundipharma
- Murdoch Childrens Research Institute
- MustGrow Biologics
- MycoMedica Life Sciences
- Mydecine Group
- Myeloid Therapeutics
- Myeloma Investment Fund
- Mymetics
- myNEO
- Myovant Sciences
- Myriad Genetics
- Myricx Bio
- Nacuity Pharmaceuticals
- Nanjing Leads Biolabs
- Nanoform
- NanoViricides
- Nantes University
- Napo EU
- Napo Pharmaceuticals
- National Cancer Institute
- National Comprehensive Cancer Network (NCCN)
- National Institute of Allergy and Infectious Diseases
- National Institute of Neurological Disorders and Stroke
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institutes of Health
- Nationwide Children’s Hospital
- Navitor Pharmaceuticals
- NBE Therapeutics
- NEC
- Nectin Therapeutics
- Nektar Therapeutics
- Nelum Pharma
- Nemysis
- NeoImmuneTech
- Neomorph
- Neotope
- Nerviano Medical Sciences
- Nestle Health Science
- NeuBase Therapeutics
- NeuExcell
- Neumentum
- Neuraly
- Neuraxpharm
- Neurgain Technologies
- Neuro3 Therapeutics
- Neurocrine Biosciences
- NeuroFront
- Neurogene
- Neurophth Therapeutics
- NeuroRx
- NeuroSense Therapeutics
- Newron Pharmaceuticals
- Neximmune
- NextCure
- Nicox
- Nightingale Health
- Nihon Medi-Physics
- Nimble Therapeutics
- Nippon Shinyaku
- NJ Bio
- Nkarta Therapeutics
- NLS Pharmaceutics
- Nona Biosciences
- Nordic Nanovector
- North Carolina State University
- Nosis Biosciences
- Novaremed
- Novartis
- Novellus Therapeutics
- Novocure
- Novo Nordisk
- Nuance Pharma
- Numab
- Nurix Therapeutics
- Nutriband
- Nuvectis Pharma
- Nuvothera
- NYU Grossman School of Medicine for Preclinical and Clinical Research
- NYU Langone Medical Center
- Obsidian Therapeutics
- Ohara Pharma
- OKYO Pharma
- Olema Oncology
- OliX Pharmaceuticals
- Omega Laboratories
- Omega Therapeutics
- Ona Therapeutics
- OncoArendi Therapeutics
- Oncoceutics
- OncoCyte
- Oncodesign
- OncoHost
- Oncology Venture
- Oncolytics Biotech
- OncoMyx Therapeutics
- OncoSec Medical
- OncoVent
- Oncovir
- ONK Therapeutics
- OnKure
- Ono Pharmaceutical
- Onward Therapeutics
- Opsis Therapeutics
- Optieum Biotechnologies
- Orbis Medicines
- Orbit Biomedical
- Orexo
- Organon
- ORIC Pharmaceuticals
- Orient EuroPharma
- Orion
- Orion Biotechnology
- Orna Therapeutics
- Orum Therapeutics
- OSE Immunotherapeutics
- Osivax
- Ossianix
- Otsuka
- Ovensa
- Ovid Therapeutics
- Oxford BioMedica
- Oxford Biomedica Solutions
- Oxford BioTherapeutics
- Oyster Point Pharma
- Palleon Pharmaceuticals
- Panbela Therapeutics
- Pandion Therapeutics
- Pantherna Therapeutics
- Papyrus Therapeutics
- Paragon Genomics
- Passage Bio
- Path BioAnalytics
- Pathogen and Microbiome Institute
- PDC*line Pharma
- Pearl Bio
- PEAR Therapeutics
- PeptiDream
- Personalis
- PersonGen BioTherapeutics
- Pfenex
- Pfizer
- PharmaEngine
- PharmaTher
- Pharming Group
- PHAXIAM Therapeutics
- Phenomic AI
- Philogen
- Phio Pharmaceuticals
- Phost’in Therapeutics
- Pieris Pharmaceuticals
- Pierre Fabre
- PineTree Therapeutics
- Pionyr Immunotherapeutics
- Plexium
- Plus Therapeutics
- Polyphor
- Poolbeg Pharma
- Portage Biotech
- Poseida Therapeutics
- Praxis Precision Medicines
- Precision BioSciences
- Prellis Biologics
- Prelude Therapeutics
- Presage Biosciences
- Prevail Therapeutics
- Prime Medicine
- ProfoundBio
- ProFound Therapeutics
- Progenity
- Prokarium
- Proteomics International
- Proteovant Therapeutics
- Prothena
- Provention Bio
- Providence Therapeutics
- Psycheceutical Bioscience
- Pulmatrix
- Puma Biotechnology
- Purdue Pharma
- Purespring Therapeutics
- PureTech Health
- Purple Biotech
- Q32 Bio
- QBiotics
- QIAGEN
- Qualigen
- Quantum Leap Health Care Collaborative
- Quebec Consortium for Drug Discovery
- Queensland Institute of Medical Research (QIMR)
- Queensland University of Technology
- Quell Therapeutics
- Quoin Pharmaceuticals
- Quris-AI
- R-Pharm
- Race Oncology
- Radiance Biopharma
- Radionetics Oncology
- Radiopharm Theranostics
- Rafael Pharmaceuticals
- Ragon Institute
- Rallybio
- Rani Therapeutics
- RayzeBio
- Recce Pharmaceuticals
- Recludix Pharma
- ReCode Therapeutics
- Recursion
- RedHill Biopharma
- RefleXion Medical
- Regeneron Pharmaceuticals
- Regenxbio
- Regional Cancer Institute of Montpellier
- Regor Therapeutics
- Regranion
- Relay Therapeutics
- Relief Therapeutics
- Remedium Bio
- Remix Therapeutics
- ReNAgade Therapeutics
- ReNeuron
- Repare Therapeutics
- Replicel Life Sciences
- RespireRx Pharmaceuticals
- Revance Therapeutics
- ReviR Therapeutics
- ReVision Optics
- Revitope Oncology
- ReviveMed
- Revive Therapeutics
- RevolKa
- Revolution Medicines
- Rgenta Therapeutics
- Rheos Medicines
- Ribometrix
- Riparian Pharmaceuticals
- Ripple Therapeutics
- Roche
- Rockwell Medical
- Roivant Sciences
- Rona Therapeutics
- Roswell Park Cancer Institute
- RQ Biotechnology
- RS BioTherapeutics
- RubrYc Therapeutics
- Rumpus Therapeutics
- Ryvu Therapeutics
- SAB Biotherapeutics
- Saga University
- Sairopa
- Salipro Biotech
- Samsung Bioepis
- Samyang Biopharmaceuticals
- SanegeneBio
- Sangamo Therapeutics
- Sanofi
- Sanofi US Services
- Santen Pharmaceutical
- Santhera Pharmaceuticals
- Sant Joan de Déu-Barcelona Children’s Hospital
- Sarah Cannon Research Institute
- Sarepta Therapeutics
- Schrodinger
- SciClone Pharmaceuticals
- SciNeuro Pharmaceuticals
- Scipher Medicine
- Scorpion Therapeutics
- Scribe Therapeutics
- Scripps Research Institute
- Scynexis
- Seagen
- Seattle Genetics
- Secarna Pharmaceuticals
- Second Genome
- Selecta Biosciences
- Senda Biosciences
- SEngine Precision Medicine
- Sensorion
- Senti Biosciences
- Sentinel Oncology
- Seres Therapeutics
- Sernova
- Serum Institute of India
- Seven and Eight Biopharmaceuticals
- Shanghai Medicilon
- Shattuck Labs
- Shenzhen Chipscreen Biosciences
- Shionogi Pharma
- Shoreline Biosciences
- Silence Therapeutics
- Silk Road Therapeutics
- Silo Pharma
- SimBioSys
- Simcere Pharmaceuticals
- Simcha Therapeutics
- Singular Genomics Systems
- Sirtex Medical
- SiSaf
- SK Biopharmaceuticals
- Skye Bioscience
- Skyhawk Therapeutics
- Sofregen Medical
- Solid Biosciences
- Soligenix
- Sonnet BioTherapeutics
- Sonoma BioTherapeutics
- Sorrento Therapeutics
- Sosei
- Sosei Heptares
- SOTIO
- Spark Therapeutics
- Sparrow Pharmaceuticals
- Spencer Health Solutions
- Spherix
- SpikImm
- SpliceBio
- Spring Bank Pharmaceuticals
- SpringWorks Therapeutics
- Spruce Biosciences
- STADA Arzneimittel
- Stahl
- Stallargenes
- Starpharma
- Stealth BioTherapeutics
- Stemline Therapeutics
- StemoniX
- St George Street Capital
- Stora Enso
- Strand Therapeutics
- StrideBio
- Stuart Therapeutics
- SUDA Pharmaceuticals
- Sumitomo Corporation
- Sumitomo Dainippon Pharma
- Sumitovant Biopharma
- Summit Therapeutics
- SunRock Biopharma
- Supernus Pharmaceuticals
- Sutro Biopharma
- Suzhou NeuPharma
- SwanBio Therapeutics
- Swedish Orphan Biovitrum
- Syena
- Symvivo
- Synaffix
- Syndax Pharmaceuticals
- SynerK
- Synlogic
- Synthetic Biologics
- Syros Pharmaceuticals
- Tachyon Therapeutics
- Taiho
- Taisho Pharmaceutical
- Taiwan Liposome Company
- Takeda Pharmaceutical
- Takeda Pharmaceuticals U.S.A
- Takeda Ventures
- Talem Therapeutics
- Talix Therapeutics
- TARA Biosystems
- Targovax
- Tautomer Bioscience
- Tavros Therapeutics
- Taysha Gene Therapies
- TB Alliance
- TekCyte
- Telix Pharmaceuticals
- Tempest Therapeutics
- TeneoBio
- TeneoOne
- Tentarix Biotherapeutics
- Terray Therapeutics
- Tetra Bio-Pharma
- Tetragenetics
- Teva Pharmaceutical Industries
- Texas A&M University
- Texcell
- TFF Pharmaceuticals
- TG Therapeutics
- Tharimmune
- Theragnostics
- Therapix Bio
- Theriva Biologics
- Thermo Fisher Scientific
- Thirona Bio
- Thomas Jefferson University
- Tiba Biotech
- Titan Pharmaceuticals
- TiumBio
- Tizona Therapeutics
- Tome Biosciences
- TONIX Pharmaceuticals
- Torii Pharmaceutical
- Torque Therapeutics
- Totus Medicines
- Toxys
- TRACON Pharmaceuticals
- Transgene
- TransThera
- TreeFrog Therapeutics
- Trevena
- Treventis
- TRexBio
- TRIANA Biomedicines
- Trio Pharmaceuticals
- Triphase Accelerator
- TriSalus Life Sciences
- TRT Innovations
- Trutino Biosciences
- TScan Therapeutics
- TTC
- Tubulis
- Tufts Medical Center
- Tufts University
- TuHURA Biosciences
- Turnstone Biologics
- Twist Bioscience
- Tyris Therapeutics
- Ubiquigent
- Ubix Therapeutics
- UCB
- Ultragenyx Pharmaceuticals
- Umoja Biopharma
- Uni-Bio Science
- Unilever
- UNION Therapeutics
- UnitedHealth
- Univercells
- Universite Laval
- University College Cork
- University College London
- University Gottingen
- University of Alberta
- University of Bonn
- University of British Columbia
- University of California San Francisco
- University of Colorado
- University of Edinburgh
- University of Florida
- University of Houston
- University of Kentucky
- University of Lausanne
- University of Leipzig
- University of Leuven
- University of Louisville
- University of L’Aquila
- University of Maryland Baltimore
- University of Massachusetts
- University of Massachusetts Medical School
- University of Melbourne
- University of Michigan
- University of Montreal
- University of North Carolina
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Sheffield
- University of Southern California
- University of Texas Medical Branch
- University of Texas Southwestern Medical Center
- University of Tubingen
- University of Virginia
- University of Wisconsin
- University of Wollongong
- UroGen Pharma
- Urovant Sciences
- UT Southwestern Medical Center
- UWM Research Foundation
- ValenzaBio
- Valo Therapeutics
- VantAI
- Variational AI
- Vaxart
- Vaxcyte
- Vaximm
- Vect-Horus
- VectivBio
- VelaVigo
- VenatoRx
- Vensica Medical
- Ventyx Biosciences
- Verastem
- Verge Genomics
- VerImmune
- Vernalis
- Verrica Pharmaceuticals
- Vertex Pharmaceuticals
- Verve Therapeutics
- Vesalius Therapeutics
- Vetophage
- Viatris
- Vici Health Sciences
- Victoria University
- ViGeneron
- Vigil Neuroscience
- Vir Biotechnology
- Vitalli Bio
- Vivace Therapeutics
- Vivet Therapeutics
- Vividion Therapeutics
- vivoPharm
- Vivoryon Therapeutics
- Vivtex
- Voluntis
- Vor Biopharma
- Voyager Therapeutics
- VyGen-Bio
- VYNE Therapeutics
- Vyriad
- Washington University in St Louis
- WaVe Lifesciences
- WAVE Life Sciences
- Weizmann Institute
- Westport Bio
- Wisconsin Alumni Research Foundation
- Wistar Institute
- Worldwide Clinical Trials
- WuXi Biologics
- WY Biotech
- X-chem
- Xencor
- Xenetic Biosciences
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xiamen Amoytop Biotech
- Xilio Therapeutics
- Xoma
- Xyphos Biosciences
- Y-Biologics
- Y2X Life Sciences
- Yale University
- Yeda Research and Development Company
- Yield10 Bioscience
- Yissum Research Development
- ZAI Laboratory
- Zambon
- Zealand Pharma
- ZebiAI Therapeutics
- Zenith Epigenetics
- Zenyaku Kogyo
- Ziopharm Oncology
- Zosano Pharma
- Zymeworks
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
